Antimicrobial agents and chemotherapy

• 

  Año 2004, Vol. 48, Número 11

  • Chloroquine Resistance in Plasmodium vivax

    J. K. Baird

    págs. 4075-4083

    

  • In Vitro Testing of Antimicrobial Activity of Bone Cement

    P. Steinrucke, T. Bechert, V. Alt

    págs. 4084-4088

    

  • Synergism between Amodiaquine and Its Major Metabolite, Desethylamodiaquine, against Plasmodium falciparum In Vitro

    S. T. Mariga

    págs. 4089-4096

    

  • Modified Fixed-Ratio Isobologram Method for Studying In Vitro Interactions between Atovaquone and Proguanil or Dihydroartemisinin against Drug-Resistant Strains of Plasmodium falciparum

    Q. L. Fivelman

    págs. 4097-4102

    

  • Antipneumococcal Activities of Two Novel Macrolides, GW 773546 and GW 708408, Compared with Those of Erythromycin, Azithromycin, Clarithromycin, Clindamycin, and Telithromycin

    L. M. Kelly, V. Matic, K. Kosowska, B. Bozdogan

    págs. 4103-4112

    

  • Activities of Two Novel Macrolides, GW 773546 and GW 708408, Compared with Those of Telithromycin, Erythromycin, Azithromycin, and Clarithromycin against Haemophilus influenzae

    K. Kosowska, K. Credito, G. A. Pankuch

    págs. 4113-4119

    

  • Chemical Diversity of Polyene Macrolides Produced by Streptomyces noursei ATCC 11455 and Recombinant Strain ERD44 with Genetically Altered Polyketide Synthase NysC

    S. E. F. Borgos, P. Bruheim

    págs. 4120-4129

    

  • Emergence of Multidrug-Resistant Salmonella enterica Serovar Typhi in Korea

    K. Lee, J. H. Yum, B. K. Lee, Y. S. Lim, D. Yong, H. S. Kim

    págs. 4130-4135

    

  • Four Variants of the Citrobacter freundii AmpC-Type Cephalosporinases, Including Novel Enzymes CMY-14 and CMY-15, in a Proteus mirabilis Clone Widespread in Poland

    E. Literacka

    págs. 4136-4143

    

  • Effects of Amoxicillin Subinhibitory Concentrations on the Cross-Protection Developed by Pneumococcal Antibodies in Mouse Sepsis Caused by an Amoxicillin-Resistant Serotype 6B Streptococcus pneumoniae Strain

    D. Tarrago, L. Aguilar, M. J. Gimenez

    págs. 4144-4147

    

  • Nevirapine Significantly Reduces the Levels of Racemic Methadone and (R)-Methadone in Human Immunodeficiency Virus-Infected Patients

    H. Stocker

    págs. 4148-4153

    

  • Novel Chemical Class of pUL97 Protein Kinase-Specific Inhibitors with Strong Anticytomegaloviral Activity

    M. Morbitzer, T. Herget, M. Freitag

    págs. 4154-4162

    

  • Multidrug Resistance of a Porin Deletion Mutant of Mycobacterium smegmatis

    C. Mailaender, J. Stephan

    págs. 4163-4170

    

  • Inhibition of Antibiotic Efflux in Bacteria by the Novel Multidrug Resistance Inhibitors Biricodar (VX-710) and Timcodar (VX-853)

    S. Mullin

    págs. 4171-4176

    

  • Promoter Sequences Necessary for High-Level Expression of the Plasmid-Associated ampC beta-Lactamase Gene bla~M~I~R~-~1

    M. D. Reisbig, N. D. Hanson

    págs. 4177-4182

    

  • Emergence and Persistence of Macrolide Resistance in Oropharyngeal Flora and Elimination of Nasal Carriage of Staphylococcus aureus after Therapy with Slow-Release Clarithromycin: a Randomized, Double-Blind, Placebo-Controlled Study

    G.-J. Scheffer, J. H. T. Tjhie, H. F. Berg

    págs. 4183-4188

    

  • Differential Maintenance of the M184V Substitution in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 by Various Nucleoside Antiretroviral Agents in Tissue Culture

    M. Petrella, M. Oliveira

    págs. 4189-4194

    

  • Pharmacodynamics of Pulse Dosing versus Standard Dosing: In Vitro Metronidazole Activity against Bacteroides fragilis and Bacteroides thetaiotaomicron

    K. H. Ibrahim, B. W. Gunderson

    págs. 4195-4199

    

  • Pharmacokinetics of Indinavir and Ritonavir Administered at 667 and 100 Milligrams, Respectively, Every 12 Hours Compared with Indinavir Administered at 800 Milligrams Every 8 Hours in Human Immunodeficiency Virus-Infected Patients

    S. L. Rawlins, F. S. Rhame, R. A. Petruschke

    págs. 4200-4208

    

  • Highly Active Anti-Pneumocystis carinii Compounds in a Library of Novel Piperazine-Linked Bisbenzamidines and Related Compounds

    M. S. Collins, P. D. Walzer, M. T. Cushion

    págs. 4209-4216

    

  • OXA-60, a Chromosomal, Inducible, and Imipenem-Hydrolyzing Class D beta-Lactamase from Ralstonia pickettii

    D. Girlich

    págs. 4217-4225

    

  • Hypermutation and the Preexistence of Antibiotic-Resistant Pseudomonas aeruginosa Mutants: Implications for Susceptibility Testing and Treatment of Chronic Infections

    B. R. Levin, Antoni Oliver González

    págs. 4226-4233

    

  • Comparative Pharmacokinetics of Intramuscular Artesunate and Artemether in Patients with Severe Falciparum Malaria

    T. T. Hien, T. M. E. Davis

    págs. 4234-4239

    

  • Evolution of the Antimicrobial Resistance of Staphylococcus spp. in Spain: Five Nationwide Prevalence Studies, 1986 to 2002

    Emilia Cercenado Mansilla, O. Cuevas, E. Bouza

    págs. 4240-4245

    

  • Concentrations of Gemifloxacin at the Target Site in Healthy Volunteers after a Single Oral Dose

    F. Islinger

    págs. 4246-4249

    

  • Complex Multiple Antibiotic and Mercury Resistance Region Derived from the r-det of NR1 (R100)

    S. R. Partridge

    págs. 4250-4255

    

  • Steady-State Pharmacokinetics of a Double-Boosting Regimen of Saquinavir Soft Gel plus Lopinavir plus Minidose Ritonavir in Human Immunodeficiency Virus-Infected Adults

    R. M. Lopez, E. Ribera

    págs. 4256-4262

    

  • Infections with Nontyphoidal Salmonella Species Producing TEM-63 or a Novel TEM Enzyme, TEM-131, in South Africa

    K. H. Keddy, D. Szabo, T. Kruger

    págs. 4263-4270

    

  • In Vivo Assessment of Drug Efficacy against Plasmodium falciparum Malaria: Duration of Follow-Up

    K. Stepniewska, W. R. J. Taylor

    págs. 4271-4280

    

  • Heterologous Expression of the Enterococcal vanA Operon in Methicillin-Resistant Staphylococcus aureus

    B. Perichon, P. Courvalin

    págs. 4281-4285